Adam Dudley

Adam Dudley is a pharmaceutical leader with expertise in managing international drug hunting projects across multiple therapeutic areas. Currently serving as a Portfolio Leader at Genentech since 2023, they previously held significant roles including Executive Director and Project Team Lead, where they managed various drug development programs through to Phase 3. With extensive experience in both North America and Europe, they have demonstrated proficiency in project management, organizational design, and strategic business initiatives. Their educational background includes a BSc in Cell Biology and Biochemistry from the University of Liverpool and a PhD in Physiology from Newcastle University.